Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bilcare GCS Expands Capabilities | Contract Pharma
Breaking News

Bilcare GCS Expands Capabilities

Bilcare Global Clinical Supplies has enhanced its ability to develop formulation dosage forms for preclinical and early-phase drugs with the addition of fluid bed granulation technology and the In-Cap capsule system.
   
The fluid bed granulation technology extends Bilcare’s solid-dosage formulation capabilities. The system is equipped with Wurster coating inserts, enabling the delivery of specialized, high-precision coating processes for granules and non-pareils for the creation of sustained- and controlled-release tablet and capsule formulations.
   
The In-Cap capsule system for preclinical and early-stage development is capable of filling several thousand capsules per hour in multiple permutations. This equipment adds development and clinical manufacturing capabilities for various formulation types, including powders, pellets, tablets and liquids.
   
According to Vincent Santa Maria, president of Bilcare GCS, Americas, the addition of new technology is part of the company’s capital investment program in its U.S. facilities. “With these upgrades, Bilcare GCS can now quickly produce a wider variety of drug dosage forms with high product quality at or above industry standards,” he said. “These investments in R&D services further prove our commitment to being a full-service partner to our global customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters